Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Drug and Biotech Stocks
Drug company stock performance was bested by biopharmaceuticals'
by William J. Storck
January 16, 2006
| A version of this story appeared in
Volume 84, Issue 3
| FOURTH-QUARTER STOCK PRICEa | CHANGE FROM THIRD-QUARTER CLOSE | CHANGE FROM 2004 CLOSE | PRICE/ EARNINGS RATIOb | ||
| HIGH | LOW | CLOSE | ||||
| MAJOR PHARMACEUTICAL COMPANIES | ||||||
| Abbott Laboratories | $44.01 | $37.63 | $39.43 | -7.0% | -14.7% | 16 |
| Baxter International | 40.04 | 36.59 | 37.65 | -5.6 | 9.2 | 19 |
| Bristol-Myers Squibb | 23.95 | 21.03 | 22.98 | -4.5 | -9.7 | 15 |
| Eli Lilly & Co. | 57.81 | 49.76 | 56.59 | 5.7 | 1.3 | 20 |
| Johnson & Johnson | 64.32 | 60.04 | 60.10 | -5.0 | -5.0 | 17 |
| Merck | 32.35 | 25.85 | 31.81 | 16.9 | 0.7 | 13 |
| Pfizer | 25.29 | 20.60 | 23.32 | -6.6 | -12.8 | 11 |
| Schering-Plough | 21.76 | 19.05 | 20.85 | -1.0 | 1.1 | 74 |
| Wyeth | 47.48 | 41.20 | 46.07 | -0.4 | 8.9 | 16 |
| C&EN pharmaceutical indexc (1992 = 100) | 354.4 | 330.1 | 347.5 | -1.1% | -2.2% | |
| Dow Jones industrial average | 10931.6 | 10215.2 | 10717.5 | 1.4% | -0.6% | |
| BIOPHARMACEUTICAL AND DRUG DISCOVERY COMPANIES | ||||||
| Amgen | $84.42 | $73.37 | $78.86 | -1.0% | 23.2% | 26 |
| Biogen Idec | 45.52 | 35.94 | 45.28 | 14.7 | -33.0 | 32 |
| Celera Genomics | 12.92 | 10.51 | 10.96 | -9.6 | -19.3 | def |
| Cephalon | 65.28 | 43.73 | 64.74 | 39.5 | 26.7 | 22 |
| Chiron | 44.85 | 43.00 | 44.44 | 1.8 | 33.4 | 97 |
| Cytogen | 3.95 | 2.74 | 2.74 | -32.2 | -75.6 | def |
| Genentech | 99.66 | 81.15 | 92.50 | 9.8 | 69.1 | 80 |
| Genzyme | 77.53 | 67.46 | 70.78 | -1.2 | 22.8 | 32 |
| Gilead Sciences | 55.63 | 45.21 | 52.57 | 7.8 | 51.0 | 38 |
| Icos | 30.18 | 25.38 | 27.63 | 0.0 | -1.1 | def |
| MedImmune | 37.06 | 32.14 | 35.02 | 4.1 | 29.3 | 152 |
| Millennium Pharmaceuticals | 10.92 | 8.09 | 9.70 | 4.0 | -19.3 | def |
| Protein Design Labs | 29.92 | 25.49 | 28.42 | 1.5 | 39.4 | def |
| Vertex Pharmaceuticals | 28.92 | 20.79 | 27.67 | 23.8 | 160.0 | def |
| Xoma | 1.83 | 1.46 | 1.60 | -9.1 | -36.7 | def |
| C&EN biopharmaceutical indexd (1992 = 100) | 581.7 | 500.4 | 567.4 | 7.3% | 21.3% | |
| NASDAQ | 2273.4 | 2037.5 | 2205.3 | 2.5% | 2.0% | |
a Adjusted for stock splits. b As of Dec. 30, 2005. c Based on the average stock price for the nine drugcompanies listed. d Based on the average stock pricefor the 15 biopharmaceutical companies listed. def = deficit in previous four quarters.
Chemicals and biotech improve in fourth quarter, but pharmaceuticals decline slightly
Some chemical stock prices suffer big declines
Drug company stock performance was bested by biopharmaceuticals'
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter